AR076306A1 - Composiciones biodisponibles de compuestos alfa -(n-sulfonamido) acetamida amorfo - Google Patents
Composiciones biodisponibles de compuestos alfa -(n-sulfonamido) acetamida amorfoInfo
- Publication number
- AR076306A1 AR076306A1 ARP100101258A ARP100101258A AR076306A1 AR 076306 A1 AR076306 A1 AR 076306A1 AR P100101258 A ARP100101258 A AR P100101258A AR P100101258 A ARP100101258 A AR P100101258A AR 076306 A1 AR076306 A1 AR 076306A1
- Authority
- AR
- Argentina
- Prior art keywords
- biodavailable
- amorfo
- alfa
- sulfonamide
- acetamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composiciones de dispersion solida amorfa que contienen (2R)-2-[[(4-clorofenil)sulfonil][[2-fluoro-4-(1,2,4-oxadiazol-3-iI)fenil]metil]amino]-5,5,5-trifluoropentanamida y polivinilpirrolidona-acetato de vinilo o succinato acetato de hidroxipropilmetilcelulosa para la formacion en comprimidos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16906609P | 2009-04-14 | 2009-04-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR076306A1 true AR076306A1 (es) | 2011-06-01 |
Family
ID=42664672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100101258A AR076306A1 (es) | 2009-04-14 | 2010-04-14 | Composiciones biodisponibles de compuestos alfa -(n-sulfonamido) acetamida amorfo |
Country Status (21)
Country | Link |
---|---|
US (1) | US20100261768A1 (es) |
EP (1) | EP2419086B1 (es) |
JP (1) | JP2012524090A (es) |
KR (1) | KR20120027142A (es) |
CN (1) | CN102387788B (es) |
AR (1) | AR076306A1 (es) |
AU (1) | AU2010236701A1 (es) |
BR (1) | BRPI1012523A2 (es) |
CA (1) | CA2758709A1 (es) |
DK (1) | DK2419086T3 (es) |
EA (1) | EA201171207A1 (es) |
ES (1) | ES2426403T3 (es) |
HR (1) | HRP20130807T1 (es) |
MX (1) | MX2011010513A (es) |
NZ (1) | NZ595411A (es) |
PL (1) | PL2419086T3 (es) |
PT (1) | PT2419086E (es) |
SI (1) | SI2419086T1 (es) |
SM (1) | SMT201300106B (es) |
TW (1) | TW201043269A (es) |
WO (1) | WO2010120662A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE430727T1 (de) | 2001-12-20 | 2009-05-15 | Bristol Myers Squibb Co | Alpha-(n-sulfonamid)acetamidderivate als beta- amyloidinhibitoren |
US8044077B2 (en) | 2009-03-19 | 2011-10-25 | Bristol-Myers Squibb Company | Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production |
US7977362B2 (en) | 2009-03-20 | 2011-07-12 | Bristol-Myers Squibb Company | Alpha-(N-benzenesulfonamido)cycloalkyl derivatives |
US8252821B2 (en) | 2009-04-14 | 2012-08-28 | Bristol-Myers Squibb Company | Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound |
AR087277A1 (es) * | 2011-07-21 | 2014-03-12 | Bristol Myers Squibb Co | Composiciones biodisponibles de compuestos amorfos de piperidinilo, composicion farmaceutica, metodos |
US20150045353A1 (en) * | 2013-08-09 | 2015-02-12 | Neurogenetic Pharmaceuticals, Inc. | Formulations containing gamma secretase modulators, methods for preparation and delivery thereof |
TWI765410B (zh) * | 2014-08-08 | 2022-05-21 | 日商中外製藥股份有限公司 | 4環性化合物的非晶質體的用途 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3999007A (en) * | 1975-10-09 | 1976-12-21 | Carl Joseph Crane | Aircraft visual approach/landing reproducer device and system |
US5136301A (en) * | 1989-08-30 | 1992-08-04 | Rockwell International Corporation | Primary flight display system having a vertical linear altimeter |
US5274094A (en) * | 1990-08-15 | 1993-12-28 | British Bio-Technology Limited | Production of heterobicyclic containing benzene sulfonamides |
GB9202791D0 (en) * | 1992-02-11 | 1992-03-25 | British Bio Technology | Compounds |
EP0750238B1 (en) * | 1995-06-20 | 2000-03-01 | Honeywell Inc. | Integrated ground collision avoidance system |
CZ291659B6 (cs) * | 1995-11-17 | 2003-04-16 | Warner-Lambert Company | Sulfonamidové inhibitory matricových metaloproteináz |
WO2000002009A1 (en) * | 1998-07-06 | 2000-01-13 | Alliedsignal Inc. | Aircraft position validation using radar and digital terrain elevation database |
US6313123B1 (en) * | 1999-01-27 | 2001-11-06 | American Cyanamid Company | Acetylenic sulfonamide thiol tace inhibitors |
US6570531B1 (en) * | 2000-04-27 | 2003-05-27 | Rockwell Collins, Inc. | Satellite navigation receiver designed for compatibility with aircraft automatic landing systems |
US6483454B1 (en) * | 2000-11-28 | 2002-11-19 | Bae Systems Aerospace Inc. | Close formation aircraft collision avoidance |
ATE430727T1 (de) * | 2001-12-20 | 2009-05-15 | Bristol Myers Squibb Co | Alpha-(n-sulfonamid)acetamidderivate als beta- amyloidinhibitoren |
RU2342374C2 (ru) * | 2003-03-31 | 2008-12-27 | Уайт | Фтор- и трифторалкилсодержащие гетероциклические сульфонамидные ингибиторы образования бета-амилоида и их производные |
US20050048112A1 (en) * | 2003-08-28 | 2005-03-03 | Jorg Breitenbach | Solid pharmaceutical dosage form |
FR2870605B1 (fr) * | 2004-05-18 | 2010-10-08 | Airbus France | Procede et dispositif de guidage automatique d'un aeronef, pour un vol au moins en partie a basse altitude |
FR2880456B1 (fr) * | 2005-01-03 | 2007-02-23 | Airbus France Sas | Procede et dispositif d'alerte sonore lors de la desactivation d'un pilote automatique d'un aeronef |
FR2886439B1 (fr) * | 2005-05-24 | 2010-11-05 | Eurocopter France | Procede et dispositif d'aide au pilotage d'un aeronef a basse altitude |
AU2006340003A1 (en) * | 2005-11-09 | 2007-09-20 | Novartis Ag | Process for making pharmaceutical compositions with a transient plasticizer |
FR2897448B1 (fr) * | 2006-02-14 | 2008-03-14 | Airbus France Sas | Procede et systeme d'aide au pilotage d'un aeronef. |
RU2008131051A (ru) * | 2006-02-17 | 2010-03-27 | Вайет (Us) | Избирательное n-сульфонилирование 2-амино трифторалкильнзамещенных спиртов |
CN101415670A (zh) * | 2006-02-17 | 2009-04-22 | 惠氏公司 | 制备磺酰胺取代醇和其中间体的方法 |
NZ571934A (en) * | 2006-03-20 | 2012-05-25 | Vertex Pharma | Methods of spray drying formulations of vx-950 (telaprevir) |
CA2645566A1 (en) * | 2006-03-20 | 2007-09-27 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions |
FR2911988B1 (fr) * | 2007-01-26 | 2016-03-25 | Airbus France | Procede et dispositif pour determiner une hauteur maximale de stabilisation lors de la phase finale de vol d'un avion |
US8084477B2 (en) * | 2007-10-31 | 2011-12-27 | Bristol-Myers Squibb Company | Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
-
2010
- 2010-04-08 TW TW099110918A patent/TW201043269A/zh unknown
- 2010-04-09 US US12/757,304 patent/US20100261768A1/en not_active Abandoned
- 2010-04-12 SI SI201030355T patent/SI2419086T1/sl unknown
- 2010-04-12 MX MX2011010513A patent/MX2011010513A/es unknown
- 2010-04-12 PL PL10714413T patent/PL2419086T3/pl unknown
- 2010-04-12 CN CN2010800160778A patent/CN102387788B/zh not_active Expired - Fee Related
- 2010-04-12 EP EP10714413.1A patent/EP2419086B1/en not_active Not-in-force
- 2010-04-12 ES ES10714413T patent/ES2426403T3/es active Active
- 2010-04-12 JP JP2012506089A patent/JP2012524090A/ja active Pending
- 2010-04-12 WO PCT/US2010/030679 patent/WO2010120662A2/en active Application Filing
- 2010-04-12 KR KR1020117024035A patent/KR20120027142A/ko not_active Application Discontinuation
- 2010-04-12 AU AU2010236701A patent/AU2010236701A1/en not_active Abandoned
- 2010-04-12 DK DK10714413.1T patent/DK2419086T3/da active
- 2010-04-12 CA CA2758709A patent/CA2758709A1/en not_active Abandoned
- 2010-04-12 PT PT107144131T patent/PT2419086E/pt unknown
- 2010-04-12 BR BRPI1012523A patent/BRPI1012523A2/pt not_active Application Discontinuation
- 2010-04-12 EA EA201171207A patent/EA201171207A1/ru unknown
- 2010-04-12 NZ NZ595411A patent/NZ595411A/xx not_active IP Right Cessation
- 2010-04-14 AR ARP100101258A patent/AR076306A1/es unknown
-
2013
- 2013-08-27 HR HRP20130807AT patent/HRP20130807T1/hr unknown
- 2013-09-24 SM SM201300106T patent/SMT201300106B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MX2011010513A (es) | 2011-11-29 |
KR20120027142A (ko) | 2012-03-21 |
AU2010236701A1 (en) | 2011-10-20 |
CN102387788A (zh) | 2012-03-21 |
US20100261768A1 (en) | 2010-10-14 |
BRPI1012523A2 (pt) | 2016-03-29 |
HRP20130807T1 (hr) | 2013-09-30 |
TW201043269A (en) | 2010-12-16 |
PT2419086E (pt) | 2013-09-04 |
JP2012524090A (ja) | 2012-10-11 |
SI2419086T1 (sl) | 2013-10-30 |
ES2426403T3 (es) | 2013-10-23 |
CA2758709A1 (en) | 2010-10-21 |
DK2419086T3 (da) | 2013-09-30 |
NZ595411A (en) | 2013-02-22 |
WO2010120662A2 (en) | 2010-10-21 |
PL2419086T3 (pl) | 2013-11-29 |
SMT201300106B (it) | 2013-11-08 |
EP2419086A2 (en) | 2012-02-22 |
CN102387788B (zh) | 2013-07-10 |
WO2010120662A3 (en) | 2011-09-15 |
EP2419086B1 (en) | 2013-06-26 |
EA201171207A1 (ru) | 2012-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR076306A1 (es) | Composiciones biodisponibles de compuestos alfa -(n-sulfonamido) acetamida amorfo | |
CL2007003832A1 (es) | Compuestos derivados de azaespiro; procedimiento de preparacion; composicion farmaceutica; y su uso para prevenir y tratar ansiedad, trastornos depresivos, entre otras enfermedades. | |
ECSP077249A (es) | Nuevos hidratos y polimorfos de 4-[[(7r)-8-ciclopentil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-2-pteridinil]amino]-3-metoxi-n-(1-metil-4-piperidinil)-benzamida, procedimiento para su preparación y su uso como fármaco | |
CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
AR069135A1 (es) | Compuesto de alfa-(n-sulfonamido) acetamida como un inhibidor de produccion de peptido beta amiloide | |
CL2007002377A1 (es) | Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno. | |
BRPI0820665A2 (pt) | compostos de peptidil nitrilas, processos para fabricação dos mesmos, composição farmacêutica, combinação e uso de ditos compostos | |
BRPI0821544A2 (pt) | mistura para a remoção de oxigênio, composição, artigo, mistura padrão, e, uso de uma mistura | |
CL2010001483A1 (es) | Compuestos derivados de 5-fenil-1h-piridin-2-ona y 6-fenil-2h-piridazin-3-ona, inhibidores de tirosina-quinasa (btk); composicion farmaceutica que comprende a dichos compuestos y su uso para el tratamiento de un estado patologico inflamatorio y/o autoinmune. | |
UY30319A1 (es) | Formulaciones de inhibidores de dpp iv | |
CL2007003756A1 (es) | Compuestos derivados de pirazolo-quinazolina sustituidos, moduladores de la actividad de proteina quinasas; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento del cancer. | |
BR112012016398A2 (pt) | Composto imidazopiridinil-aminopiridino substituído, composição farmacêutica que compreende o referido composto e uso do mesmo para o tratamento de uma doença celular proliferativa | |
CL2007001885A1 (es) | Compuestos derivados de urea de tropano, moduladores de la actividad de la 11betahsd1; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como obesidad, diabetes, hipertension, aterosclerosis, demencia y osteoporosis. | |
BRPI0819299A2 (pt) | Uso de composição, e, composição contendo proteína | |
ATE549019T1 (de) | 1-ä(3-hydroxy-adamant-1-ylamino)-acetylü- pyrrolidin-2(s)-carbonitril-formulierung mit modifizierter freisetzung | |
BRPI0915137A2 (pt) | uso de pelo menos um composto, peptídeo, e, formulação farmacêutica | |
BRPI0921699A2 (pt) | complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo | |
AR064149A1 (es) | Sal fumarato de (alfa s , beta r)-6 bromo- alfa-[ 2(dimetilamino ) etil)-2- metoxi - alfa-1-naftalenil- beta- fenil-3- quinolinaetanol | |
BRPI0717699A2 (pt) | "composição e seus processos de preparação, uso de uma composição e uso coméstico de uma composição! | |
BRPI0915136A2 (pt) | uso de pelo menos um composto, peptídeo, e, formulação farmacêutica | |
CL2007001630A1 (es) | Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c. | |
CL2007002376A1 (es) | Compuestos derivados de pirrol sustituido; proceso de preparacion; composicion farmaceutica; y uso en enfermedades bacterianas. | |
IL206562A0 (en) | Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition | |
EP1850875A4 (en) | PROTEIN CARBON COMPOSITION WITH LONG-TERM RELIEF | |
IL191758A0 (en) | Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |